Unique ID issued by UMIN | UMIN000012449 |
---|---|
Receipt number | R000014222 |
Scientific Title | NV membrane can Improve the Tendency of Oxidative Stress during HD, Preliminary Study |
Date of disclosure of the study information | 2013/11/30 |
Last modified on | 2017/12/05 14:33:58 |
NV membrane can Improve the Tendency of Oxidative Stress during HD, Preliminary Study
NVITOS Preliminary Study
NV membrane can Improve the Tendency of Oxidative Stress during HD, Preliminary Study
NVITOS Preliminary Study
Japan |
Hemodialysis
Medicine in general | Endocrinology and Metabolism | Nephrology |
Urology |
Others
NO
Reduction inspects blood oxidation stress markers or inflammatory markers level by using NV whether possible.
Efficacy
Confirmatory
Pragmatic
Not applicable
Use NV dialyzer and conventional polysulfone dialyzer and compare the blood marker levels.
Measurement marker
Plasma free radical
IL-6
Pentraxin 3
Fetuin A
High sensitive CRP
Homocysteine
Pentosidine
Interventional
Cross-over
Non-randomized
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Change from using conventional polysulfone dialyzer to using good biocompatibility dialyzer(NV) (for 6 months).
Change from using good biocompatibility dialyzer(NV) to using conventional polysulfone dialyzer (for 6 months).
20 | years-old | <= |
Not applicable |
Male and Female
1) The patients whose age is between 20 and 80 years at the time of enrollment in this study.
2) The patients who are using polysulfone dialyzers (NV or except NV).
1) A patient who is treated with other renal insufficiency therapies, continuous ambulatory peritoneal dialysis and hemodiafiltration, excluding hemodialysis.
2) A patient who is enrolled to other clinical study.
3) Cancer bearing patients.
4) A patient who has anamnestic cardiovascular diseases (heart attack, stroke) in less than 3 months.
5) A patient who is consider as onset of acute inflammation.
6) A patient who is a pregnant or intends to become a pregnant within one year.
8) A patient who is judged as the inadequate subject of this study by the doctor.
8
1st name | |
Middle name | |
Last name | Tadashi Tomo |
Oita university hospital
Blood Purification Center
879-5593 Idai-gaoka, 1-1, Hasama-machi, Yufu-city, Oita, Japan
097-549-5804
tomo@oita-u.ac.jp
1st name | |
Middle name | |
Last name | Kaede Ishida |
Oita university hospital
Blood Purification Center
879-5593 Idai-gaoka, 1-1, Hasama-machi, Yufu-city, Oita, Japan
097-549-5804
Kaede-m-06@oita-u.ac.jp
Oita university hospital
Blood Purification Center
Toray Industries, Inc.
Profit organization
Japan
NO
医療法人社団 顕腎会大分内科クリニック(大分県)
2013 | Year | 11 | Month | 30 | Day |
Unpublished
Completed
2013 | Year | 11 | Month | 30 | Day |
2013 | Year | 12 | Month | 01 | Day |
2014 | Year | 09 | Month | 30 | Day |
2013 | Year | 11 | Month | 30 | Day |
2017 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014222
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |